The detrimental effect of antibiotics on the efficacy of immune checkpoint inhibitors (ICIs), does not extend to chemo-immunotherapy combinations in patients with lung cancer, new research shows. An international multicentre study involving 302 patients with stage IV NSCLC found no effect of prior (n= 47 patients) or current antibiotic therapy on the efficacy of first ...
Chemo-immunotherapy combination efficacy not impaired by antibiotics
By Michael Woodhead
25 Oct 2021